Pharma2026-10-16 09:28 UTC
Digital Biomanufacturing Market to be Transformed by AI and Automation
The digital biomanufacturing market is expected to be driven by the increasing adoption of AI and automation in biopharmaceutical production.
The digital biomanufacturing market is expected to grow significantly in the coming years, driven by the increasing adoption of artificial intelligence (AI) and automation in biopharmaceutical production. Biomanufacturers are turning to digital twins and simulation-driven design to optimize their processes and improve efficiency. This trend is expected to continue as companies seek to reduce costs and improve product quality.
Source: openPR.com — read the original article
This article is an independent rewrite and summary, not a reproduction of the original.
← back to feed
This article is an independent rewrite and summary, not a reproduction of the original.